
SymBioVault presents at CV Summit 2026 in Zurich
SymBioVault and CoreLedger presented a joint concept at CV Summit 2026, exploring the potential use of blockchain technology in personalized microbiome biobanking.

SymBioVault has joined Technologie Forum Zug (tfz), strengthening our connections within Zug’s technology and innovation ecosystem and creating new opportunities for exchange and collaboration across business, technology and research.

As a Zug-based biotech company, SymBioVault is developing a new approach to personal microbiome preservation: enabling individuals to collect, analyse and securely preserve their healthy microbiome for potential future use.
Joining the Technologie Forum Zug (tfz) connects SymBioVault with a strong regional network of companies, technology leaders, researchers and innovators. For us, this creates valuable opportunities to exchange expertise, build new relationships and explore future collaborations.
SymBioVault operates at the intersection of medical science, biotechnology and personalized health solutions. Being part of a network that brings together business, technology and research is therefore a natural step in the company’s development and strengthens our engagement with the innovation ecosystem in Zug and Switzerland.
We look forward to contributing to the tfz community, exchanging ideas with its members and developing new connections as SymBioVault continues to grow.

SymBioVault and CoreLedger presented a joint concept at CV Summit 2026, exploring the potential use of blockchain technology in personalized microbiome biobanking.

SymBioVault and ZHAW have launched a Proof-of-Concept study exploring the collection, analysis and long-term cryopreservation of personal microbiome samples - an important step toward scientifically validated microbiome biobanking.